Article
Relationship of Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Polymorphisms with Overall Cancer Susceptibility: An Updated Meta-Analysis of 28 Studies with 60 612 Subjects.
Medical science monitor : international medical journal of experimental and clinical research - 24 May 2021
Zhang Wenjing, Song Yuxuan, Zhang Xiangcheng
Abstract excerpt
BACKGROUND Programmed death-1 and its ligand-1 (PD-1/PD-L1) regulate tumor immunotherapy. A large number of studies have explored the relationship between PD-1, PD-L1, and different tumor susceptibility. However, these conclusions are not always consistent. Therefore, we updated this meta-analysis. MATERIAL AND METHODS MEDLINE, Web of Science, EMBASE and other databases were searched systematically to obtain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
